Rudolf de Boer is a Clinical Cardiologist and a Professor of (translational) Cardiology at the University Medical Center Groningen, the Netherlands. I studied medicine at the University of Groningen and, previous to my current appointment, I completed a research fellowship at the University of Utah, Salt Lake City, USA, a PhD program at the University of Groningen and a post-doctoral fellowship at HarvardMedicalSchool, Boston, USA.
My research group focuses on novel genes involved in cardiac remodeling, fibrosis, and metabolic changes and diabetes. The last 10 years, I have studied galectin-3 in clinical heart failure and in the general population, and focused on its role in the pathophysiology of heart failure. My clinical interests are cardiogenetics, neuromuscular disorders, echocardiography and end-stage heart failure including VAD therapy and transplant. I have authored and co-authored over 300 articles in peer reviewed journals and wrote over 10 book chapters.
For my work, I received several grants from the Netherlands Heart Foundation and the Dutch Organization for Scientific Research (VENI 2009, VIDI 2013) and an ERC consolidator grant (ERC Cons) in 2019. I was a member the scientific committee of LifeLines (www.lifelines.net), and was appointed a Fellow of the European Society of Cardiology (ESC) in 2010. I furthermore is the president of the Heart Failure Working Group of the Dutch Society of Cardiology, member of the ESC Translational Committee, and in 2014 I was elected as board member of the Heart Failure Association of the ESC.
I have served as an Associate Editor of the European Journal of Heart Failure, as well as being reviewer for several other journals, including Circulation, Journal of the American College of Cardiology, Hypertension, and the European Heart Journal.